Trapianti e terapia genetica: aspetti personalisticiGALLO, Maria Letizia; PALERMO, Massimo.Medicina e morale. 2005, Vol 55, Num 1, pp 258-258, issn 0025-7834, 1 p.Conference Paper

Cardiovascular Gene TherapyHAJJAR, Roger J.Gene therapy (Basingstoke). 2012, Vol 19, Num 6, issn 0969-7128, 120 p.Serial Issue

The British Society for Gene Therapy (BSGT). Annual ConferenceHuman gene therapy. 2010, Vol 21, Num 4, pp 487-525, issn 1043-0342, 39 p.Conference Paper

Pois(s)on: It's a question of dose..FEHSE, B; KUSTIKOVA, O. S; BUBENHEIM, M et al.Gene therapy (Basingstoke). 2004, Vol 11, Num 11, pp 879-881, issn 0969-7128, 3 p.Article

La thérapie géniqueAnnales de l'Institut Pasteur. Actualités. 1999, Vol 10, Num 3-4, issn 0924-4204, 70 p.Serial Issue

Bacterial Vectors for Gene & Cell TherapyTANGNEY, Mark; GAHAN, Cormac G. M.Current gene therapy. 2010, Vol 10, Num 1, issn 1566-5232, 77 p.Serial Issue

Baculovirus: A Promising Vector for Gene Therapy?HU, Yu-Chen.Current gene therapy. 2010, Vol 10, Num 3, issn 1566-5232, 89 p.Serial Issue

Convergence of Opposite Sciences for the Future Development of Non Viral Gene TherapyPITARD, Bruno.Current gene therapy. 2008, Vol 8, Num 5, issn 1566-5232, 112 p.Serial Issue

BSGT (British Society for Gene Therapy) Annual Conference 2008Human gene therapy. 2008, Vol 19, Num 4, pp 402-422, issn 1043-0342, 20 p.Conference Paper

Prospects of RNAi Therapy for CancerDAVIDSON, B.Gene therapy (Basingstoke). 2006, Vol 13, Num 6, issn 0969-7128, 121 p.Serial Issue

Therapeutic Approaches to Muscular DystrophiesGOYENVALLE, Aurélie.Current gene therapy. 2012, Vol 12, Num 3, issn 1566-5232, 124 p.Serial Issue

Gene Therapy Continues to Make Progress: Clinical and Regulatory PerspectivesCASTRO, Maria G; LOWENSTEIN, Pedro R.Current gene therapy. 2009, Vol 9, Num 5, issn 1566-5232, 109 p.Serial Issue

BSGT Annual ConferenceHuman gene therapy. 2009, Vol 20, Num 4, pp 390-422, issn 1043-0342, 32 p.Conference Paper

Cellular Vehicles for Gene TherapyCURIEL, David T.Gene therapy (Basingstoke). 2008, Vol 15, Num 10, issn 0969-7128, 106 p.Serial Issue

AAV Vectors for Clinical Gene TherapyKOTKIN, Robert M; NIRENBERG, M.Gene therapy (Basingstoke). 2008, Vol 15, Num 11, issn 0969-7128, 71 p.Serial Issue

Advanced methods for industrial production, purification, and characterization of gene vectorsBAGNIS, Claude; MERTEN, Otto-Wilhelm; MEZZINA, Mauro et al.Gene therapy (Basingstoke). 2005, Vol 12, issn 0969-7128, 180 p., SUP1Conference Proceedings

Les bases de la thérapie génique = Gene therapyJORDAN, B. R.Journal de génétique humaine. 1989, Vol 37, Num 4-5, pp 283-288, issn 0021-7743, 6 p.Article

Updates on Current Advances in Gene TherapyTANI, Jowy; FAUSTINE; TANI SUFIAN, Jomiany et al.West indian medical journal. 2011, Vol 60, Num 2, pp 188-194, issn 0043-3144, 7 p.Article

Design, production, use and regulation (Brussels, 12-14 March 1998)International conference on vectors for gene therapy. 1998, 28, [76] pConference Proceedings

Gene therapy in humans : a new era beginsKELLEY, W. N.Annals of internal medicine. 1991, Vol 114, Num 8, pp 697-698, issn 0003-4819, 2 p.Article

Orphan Drugs, Big PharmaPHILIPPIDIS, Alex.Human gene therapy. 2011, Vol 22, Num 9, pp 1037-1040, issn 1043-0342, 4 p.Article

Adenoviral vectors for gene therapyDOUGLAS, Joanne T.Molecular biotechnology. 2007, Vol 36, Num 1, pp 71-80, issn 1073-6085, 10 p.Article

Transposons for gene therapy!IVICS, Zoltan; IZSVAK, Zsuzsanna.Current gene therapy. 2006, Vol 6, Num 5, pp 593-607, issn 1566-5232, 15 p.Article

Lessons learned from gene therapy concerning and the use of integrating vectors and the possible risk of insertional oncogenesisCICHUTEK, K.Developments in biologicals. 2006, Vol 123, pp 29-34, issn 1424-6074, 6 p.Conference Paper

Controllable Expansion of Primary Cardiomyocytes by Reversible ImmortalizationYUE ZHANG; NUGLOZEH, Edem; TOURE, Fatouma et al.Human gene therapy. 2009, Vol 20, Num 12, pp 1687-1696, issn 1043-0342, 10 p.Article